I am notoriously a glass half empty sort of bloke,
but to me this is excellent news for the long
term. A much larger trial allowing for much
more weighty evidence for applications to
TGA and FDA.
Ann: Phase 2 Synovial Fluid Biomarker Study Update, page-7
Add PAR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
21.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $73.55M | |||
| Open | High | Low | Value | Volume |
| 22.0¢ | 22.0¢ | 21.0¢ | $68.04K | 319.7K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 5 | 77644 | 21.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 21.5¢ | 31843 | 6 |
View Market Depth
| Last trade - 10.47am 14/10/2024 (20 minute delay) ? |
| PAR (ASX) Chart |